Dow Jones

38,747.42

-0.31%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Targanta Therapeutics Corp (MM) (TARG)
Targanta Therapeutics Corp (MM) (TARG) Noticias

TARG

Targanta Therapeutics Corp (MM) (TARG)

Targanta Therapeutics Corp (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TARG

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/02/2009	05:06	Edgar (US Regulatory)	(25-NSE)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/02/2009	09:50	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/02/2009	09:05	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/02/2009	09:05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/02/2009	07:30	Marketwired	The Medicines Company Announces Completion of Tender Offer for Shares of Targanta Therapeutics	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
20/02/2009	06:58	Business Wire	Targanta Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
17/02/2009	15:12	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
27/01/2009	13:43	Edgar (US Regulatory)	Statement of Ownership: Solicitation (SC 14D9)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
27/01/2009	12:08	Marketwired	The Medicines Company Commences Tender Offer for All Outstanding Shares of Targanta Therapeutics	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
27/01/2009	11:54	Edgar (US Regulatory)	Tender offer statement by Third Party (SC TO-T)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
27/01/2009	05:04	Edgar (US Regulatory)	Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
27/01/2009	05:01	Edgar (US Regulatory)	Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
22/01/2009	15:49	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
14/01/2009	16:20	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
12/01/2009	21:34	Marketwired	The Medicines Company to Acquire Targanta Therapeutics	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
18/12/2008	15:05	Business Wire	Targanta Announces Corporate Restructuring	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
08/12/2008	22:52	Business Wire	FDA Issues Complete Response Letter for Oritavancin	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
03/12/2008	05:00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/11/2008	13:49	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
24/11/2008	09:32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
19/11/2008	20:17	Business Wire	FDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure Infections	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
18/11/2008	08:52	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
17/11/2008	11:29	Business Wire	Targanta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritav...	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
12/11/2008	07:02	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
12/11/2008	06:58	Business Wire	Targanta Reports Third-Quarter 2008 Financial Results	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
05/11/2008	06:58	Business Wire	Targanta Therapeutics to Present at November 2008 Investor Conferences	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
26/10/2008	11:15	Business Wire	Targanta Presents Efficacy & Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin & Skin Structure...	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
26/10/2008	10:15	Business Wire	Targanta Therapeutics Presents Data on Mechanisms That Underly Oritavancin’s Bactericidal Activity	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/10/2008	11:15	Business Wire	Targanta Presents Preclinical In Vivo Data Demonstrating Activity of Oritavancin against Clostridium Difficile Infection	NASDAQ:TARG	Targanta Therapeutics Corp (MM)
25/10/2008	11:15	Business Wire	Targanta Therapeutics Presents In Vitro Data Highlighting Oritavancin’s Potent Activity Against Gram-Positive Pathogens	NASDAQ:TARG	Targanta Therapeutics Corp (MM)